Creating a new tool to measure physical function in people with multiple sclerosis
Development of a Full Qualification Package (FQP) for the PROMISnq Short Form v2.0 - Physical Function - Multiple Sclerosis 15a (DDT COA #000123)
This study is working on a new tool to help people with multiple sclerosis share how their physical abilities are affected by the condition, so that doctors and researchers can better understand the impact of treatments on their daily lives.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Critical Path Institute NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10834506 on NIH RePORTER |
What this research studies
This research aims to develop a comprehensive qualification package for a new patient-reported outcome measure specifically designed for individuals with multiple sclerosis (MS). The focus is on creating a reliable and valid tool that reflects the physical functioning of MS patients, which can be used in drug development and clinical assessments. By gathering quantitative evidence and submitting this to the FDA, the researchers hope to ensure that this measure is recognized as suitable for evaluating the impact of treatments on physical function in MS. This initiative is driven by the need for a standardized approach that incorporates the patient perspective in assessing their health-related quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with any form of multiple sclerosis.
Not a fit: Patients with conditions other than multiple sclerosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a validated tool that improves the assessment of physical function in MS patients, leading to better treatment outcomes.
How similar studies have performed: Previous research has successfully developed patient-reported outcome measures for other conditions, indicating potential for success in this novel approach for MS.
Where this research is happening
Tucson, United States
- Critical Path Institute — Tucson, United States (Active)
Researchers
- Principal investigator: Eremenco, Sonya — Critical Path Institute
- Study coordinator: Eremenco, Sonya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.